FDA Updates Guidance for In Vitro Diagnostic Devices Under CLIA Waiver Program

Summary

The Food and Drug Administration (FDA) has released a final guidance document updating recommendations for manufacturers of in vitro diagnostic devices seeking CLIA waiver applications, incorporating changes from the 21st Century Cures Act